CSE PREV
LAST 0.57
CHANGE -0.03
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.57
CHANGE: -0.03
OTC: PRVCF
FSE: 18H

PreveCeutical Medical Inc. develops innovative options for preventive and curative therapies.

Investor Information

About Us

PreveCeutical Medical Inc. is focused on utilising nature and science for the benefit of health-conscious consumers.  With its vested interest in the preventive health sector, PreveCeutical, in collaboration with its partners, researches and develops innovative solutions that will provide consumers with options for preventive and curative therapies.

Read More

CELLB9®

PreveCeutical is building a portfolio of enhanced natural health brands. We would like to introduce CELLB9® an alternative health product containing peptides from the Caribbean Blue Scorpion. For more information on this product, or if you’d like to purchase please visit us at

www.cellb9.com

Sol-Gel Delivery Platform

for Nose-to-Brain Delivery of Therapeutic Compounds

Learn more

Nature Identical™ Peptides from the Caribbean Blue Scorpion Venom

to Assist with Cancer-Targeted Treatment

Learn more

Dual Gene Therapy

Targeting Both Diabetes and Obesity

Learn more